Penumbra Ownership | Who Owns Penumbra?
Penumbra Ownership Summary
Penumbra is owned by 89.60% institutional investors, 3.51% insiders, and 6.88% retail investors. Fmr is the largest institutional shareholder, holding 15.07% of PEN shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.26% of its assets in Penumbra shares.
PEN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Penumbra | 89.60% | 3.51% | 6.88% |
Sector | Healthcare Stocks | 279.15% | 10.63% | -189.78% |
Industry | Medical Device Stocks | 32.07% | 10.57% | 57.35% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Fmr | 5.82M | 15.07% | $1.38B |
Blackrock | 4.26M | 10.99% | $765.80M |
Blackrock funding, inc. /de | 4.11M | 10.64% | $975.90M |
Vanguard group | 3.65M | 9.45% | $866.95M |
Champlain investment partners | 1.50M | 3.87% | $355.26M |
Price t rowe associates inc /md/ | 1.27M | 3.28% | $300.58M |
State street | 1.23M | 3.18% | $221.87M |
Rtw investments, lp | 742.11K | 1.92% | $133.56M |
Baillie gifford | 730.23K | 1.89% | $173.42M |
T. rowe price investment management | 707.06K | 1.83% | $167.91M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Pfm health sciences, lp | 166.26K | 2.45% | $39.48M |
Oak harbor wealth partners | 33.61K | 2.32% | $7.98M |
Champlain investment partners | 1.50M | 2.25% | $355.26M |
Rock springs capital management lp | 240.00K | 2.17% | $57.00M |
Rtw investments, lp | 742.11K | 2.07% | $133.56M |
Carret asset management | 79.00K | 2.05% | $18.76M |
Exome asset management | 9.00K | 1.61% | $2.14M |
Braidwell lp | 183.83K | 1.29% | $43.66M |
Bellevue group | 238.05K | 1.09% | $56.53M |
Congress asset management co /ma | 608.96K | 0.98% | $144.62M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Norges bank | 229.05K | 0.01% | 229.05K |
T. rowe price investment management | 707.06K | 0.10% | 227.51K |
Blackrock | 4.26M | 0.02% | 193.91K |
Baillie gifford | 730.23K | 0.13% | 138.39K |
Adage capital partners gp | 100.50K | 0.04% | 100.50K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Capital research global investors | - | - | -1.13M |
William blair investment management | - | - | -883.10K |
Price t rowe associates inc /md/ | 1.27M | 0.03% | -719.57K |
Eagle asset management | - | - | -327.93K |
Jpmorgan chase | 131.03K | 0.00% | -253.11K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 229.05K | 0.01% | 229.05K | $54.40M |
Adage capital partners gp | 100.50K | 0.04% | 100.50K | $23.87M |
Wcm investment management | 56.47K | 0.03% | 56.47K | $13.45M |
First trust advisors lp | 41.96K | 0.01% | 41.96K | $9.97M |
Susquehanna fundamental investments | 33.58K | 0.11% | 33.58K | $7.98M |
Sold Out
Holder | Change |
---|---|
Harbor investment advisory | -1.00 |
Sjs investment consulting | -1.00 |
Dinuzzo private wealth | -1.00 |
Innealta capital | -1.00 |
Jfs wealth advisors | -2.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 440 | 15.49% | 34,552,725 | -1.08% | 89 | 1.09% | 237 | 24.74% | 130 | -2.99% |
Dec 31, 2024 | 188 | -46.29% | 15,184,979 | -56.57% | 39 | 0.48% | 87 | -42.00% | 67 | -53.15% |
Sep 30, 2024 | 346 | -3.89% | 34,876,344 | -1.99% | 90 | 1.07% | 147 | -25.76% | 142 | 33.96% |
Jun 30, 2024 | 357 | -2.99% | 35,576,747 | 6.43% | 91 | 1.21% | 196 | 7.10% | 105 | -1.87% |
Mar 31, 2024 | 368 | 0.55% | 33,426,131 | -2.90% | 87 | 1.09% | 183 | 3.98% | 107 | -13.71% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
iShares Core S&P Mid-Cap ETF | 1.26M | 3.26% | 656.00 |
Vanguard Total Stock Mkt Idx Inv | 1.18M | 3.04% | 3.32K |
Vanguard US Total Market Shares ETF | 1.16M | 3.02% | 924.00 |
Fidelity Select Health Care | 1.08M | 2.79% | -5.00K |
Vanguard Small Cap Index | 922.88K | 2.38% | 4.28K |
Fidelity Select Medical Tech and Devcs | 819.75K | 2.12% | -5.25K |
US Small-Cap Growth II Equity Comp | 807.21K | 2.08% | -1.98K |
T. Rowe Price Health Sciences | 639.14K | 1.65% | 78.70K |
Fidelity Advisor Health Care I | 618.00K | 1.60% | -10.00K |
Strategic Advisers Fidelity US TtlStk | 609.90K | 1.57% | -3.00K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jul 23, 2025 | Elsesser Adam | CEO and President | Sell | $912.05K |
Jul 23, 2025 | Elsesser Adam | CEO and President | Sell | $2.01M |
Jul 23, 2025 | Elsesser Adam | CEO and President | Sell | $842.33K |
Jul 09, 2025 | Elsesser Adam | CEO and President | Sell | $336.32K |
Jul 09, 2025 | Elsesser Adam | CEO and President | Sell | $301.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 20 |
2025 Q2 | - | 104 |
2025 Q1 | - | 59 |
2024 Q4 | - | 36 |
2024 Q3 | - | 32 |
PEN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools